Home » Webinars » Advisor Live: Antimicrobial Stewardship - Why Now and How?

Advisor Live: Antimicrobial Stewardship - Why Now and How?

October 18, 2016

This 90-minute webinar discusses strategies and tools for implementing antimicrobial stewardship programs, including methods for measuring antimicrobial use and resistance. Join Premier’s free Advisor Live® webinar series for a special Get Smart About Antibiotics Week presentation on Thursday, November 19 from 12-1:30 p.m. EST. The panel for this 90-minute webinar will discuss strategies and tools for implementing antimicrobial stewardship programs, including methods for measuring antimicrobial use and resistance. EXPERT PRESENTERS: - Gina Pugliese, RN, MS, vice president, Premier Safety Institute®, moderator - Arjun Srinivasan, MD, (CAPT, USPHS) medical director of the CDC’s Get Smart for Healthcare program, will highlight the national focus on antibiotic stewardship and reasons for the current urgency - Michael Postelnick, RPh, BCPS AQ- Infectious Diseases, clinical manager and senior infectious diseases pharmacist for Northwestern Memorial Hospital, will share lessons learned from implementing their antibiotic stewardship program - Craig Barrett, Pharm.D., BCPS, director safety solutions for Premier, Inc. will share strategies from Premier member hospitals striving for antimicrobial stewardship

Previous Presentation

Advisor Live: Optimizing Outcomes and Managing Costs - IV Acetaminophen and Liposomal Bupivacaine

Multimodal pain management is a treatment philosophy using multiple modalities to control post-operative pa...

Next Presentation

Advisor Live: Hepatitis C Screening and Linkage to Care

Hepatitis C (HCV) is the leading cause of liver transplants in the U.S., with an estimated cost of $600,000...

Advisor Live: Antimicrobial Stewardship - Why Now and How?

Previous Presentation

Next Presentation

Other content in this Stream

CMS published the outpatient prospective payment system (OPPS) interim final rule and the Medicare physician fee schedule (PFS) final rule on November 1 and 2, 2016.

Medical epidemiologist Dr. Kavita Trivedi shares her deep wealth of knowledge to help your organization implement and meet the challenges of antimicrobial stewardship.

Understand the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Quality Payment Program final rule with comment period, and implications for eligible clinicians and hospitals.

On July 25, 2016, CMS released a proposed rule to establish three new bundled payment policies for AMI, CABG and SHFFT. Collectively, the models are referred to as Episode Payment Models (EPMs).

The Centers for Medicare & Medicaid Services (CMS) published the proposed payment rules on the outpatient prospective payment system (OPPS) and the Medicare physician fee schedule (PFS) on July 14 and

This presentation highlights the rapid shift to value-based care that's occurring in the healthcare industry and was originally presented at Premier's annual Governance Conference.

In this webinar, you will hear about a uniquely effective approach ProHealth has used to directly engage their providers and address the enterprise-wide challenge of unwarranted (and very expensive) c

Presented as part of Premier's AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epide

What does the future hold for pharmacy benefit managers (PBMs)? This webinar discusses: How to better manage patients; Advantages of formulary ownership; Is PBM transparency an answer to controlling

The Centers for Medicare & Medicaid Services (CMS) recently issued a proposed rule establishing a new mandatory payment model for Medicare Part B drugs. CMS said the two-phase model would test whether

Multimodal pain management is a treatment philosophy using multiple modalities to control post-operative pain with minimal side effects. Various agents (opioid vs. non-opioid), routes (oral, intraveno

Hepatitis C (HCV) is the leading cause of liver transplants in the U.S., with an estimated cost of $600,000 per case. The Centers for Disease Control and Prevention (CDC) recommends HCV testing for ev